{
    "clinical_study": {
        "@rank": "122632", 
        "arm_group": [
            {
                "arm_group_label": "CPAP+CC", 
                "arm_group_type": "Active Comparator", 
                "description": "CPAP therapy for sleep apnea and contact control (placebo/sham for cognitive-behavioral therapy for insomnia)"
            }, 
            {
                "arm_group_label": "sham CPAP+CC", 
                "arm_group_type": "Sham Comparator", 
                "description": "sham CPAP (ineffective CPAP--placebo/sham for sleep apnea) and contact control (placebo/sham for cognitive-behavioral therapy for insomnia)"
            }, 
            {
                "arm_group_label": "CPAP+CBT", 
                "arm_group_type": "Active Comparator", 
                "description": "CPAP therapy for sleep apnea and cognitive-behavioral therapy for insomnia"
            }
        ], 
        "brief_summary": {
            "textblock": "Nearly half of all patients with obstructive sleep apnea have insomnia symptoms, and in\n      some, but not all cases, these insomnia symptoms are caused by the obstructive sleep apnea.\n      The purpose of this study is to find out what type of insomnia symptoms are caused by\n      obstructive sleep apnea and therefore most likely to respond to obstructive sleep apnea\n      treatment with continuous positive airway pressure (also known as CPAP) and if additional\n      treatment with cognitive-behavioral therapy for insomnia is beneficial."
        }, 
        "brief_title": "Understanding the Sleep Apnea/Insomnia Interaction", 
        "condition": [
            "Sleep Apnea Syndromes", 
            "Sleep Initiation and Maintenance Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Initiation and Maintenance Disorders", 
                "Sleep Apnea Syndromes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Sleep Apnea\n\n          2. Insomnia\n\n          3. Age >18\n\n        Exclusion Criteria:\n\n          1. Sedative/psychoactive drug use recently\n\n          2. Other clinically significant sleep disorders\n\n          3. Previous treatment for OSA\n\n          4. Requires oxygen or bilevel PAP therapy\n\n          5. Clinically unstable medical condition\n\n          6. Recent shift work\n\n          7. Significant alcohol use\n\n          8. Other clinically significant causes of insomnia\n\n          9. Illicit drug use\n\n         10. Prescription stimulants\n\n         11. Safety restrictions\n\n         12. Unable to treat sleep apnea with positive airway pressure therapy\n\n         13. Communication barriers\n\n         14. Cognitive impairment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01824472", 
            "org_study_id": "814153", 
            "secondary_id": "R34HL109462"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "CPAP+CC", 
                    "CPAP+CBT"
                ], 
                "description": "Treatment for sleep apnea", 
                "intervention_name": "CPAP", 
                "intervention_type": "Device", 
                "other_name": "Continuous positive airway pressure therapy"
            }, 
            {
                "arm_group_label": "CPAP+CBT", 
                "description": "Treatment for insomnia", 
                "intervention_name": "CBT", 
                "intervention_type": "Behavioral", 
                "other_name": "Cognitive-Behavioral Therapy for Insomnia"
            }, 
            {
                "arm_group_label": "sham CPAP+CC", 
                "description": "Placebo for sleep apnea", 
                "intervention_name": "sham CPAP", 
                "intervention_type": "Device", 
                "other_name": "Sham (placebo) continuous positive airway pressure"
            }, 
            {
                "arm_group_label": [
                    "CPAP+CC", 
                    "sham CPAP+CC"
                ], 
                "description": "Placebo (sham) for insomnia", 
                "intervention_name": "CC", 
                "intervention_type": "Behavioral", 
                "other_name": "Contact control"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19104"
                }, 
                "name": "University of Pennsylvania Health System"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Understanding the Sleep Apnea/Insomnia Interaction: a CPAP/Sham-CPAP Trial", 
        "overall_contact": {
            "email": "ngoonera@mail.med.upenn.edu", 
            "last_name": "Nalaka Gooneratne, MD", 
            "phone": "215 349 5948"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States:  University of Pennsylvania IRB#3", 
                "United States:  University of Pennsylvania Office of Human Research", 
                "United States:  University of Pennsyvlania Clinical and Translational Research Center"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Insomnia Severity Index Score", 
            "safety_issue": "No", 
            "time_frame": "Day 42"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01824472"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Pennsylvania", 
            "investigator_full_name": "Nalaka Gooneratne", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Pennsylvania", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Pennsylvania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}